INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Inogen Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.55+0.30 (+4.80%)
Close on Oct 19, 2026
- Market cap
- $177.15M
- P/E (TTM)
- –
- Dividend yield
- –
Inogen Inc revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $53.83M | $47.44M | $49.20M | $53.99M | $56.35M | $50.30M | $51.77M | $56.51M | $58.23M | $51.99M | $54.37M | $58.35M | 56.6% | -4.5% |
| Non-U.S. revenue | $41.25M | $37.67M | $32.52M | $38.40M | $35.92M | $31.99M | $28.31M | $32.33M | $30.53M | $26.04M | $21.52M | $25.61M | 43.4% | +14.8% |
From the segment and revenue-disaggregation notes of Inogen's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.